| Structure |
Chemical Name |
CAS |
MF |
 |
ニトロスカネイト |
19881-18-6 |
C13H8N2O3S |
 |
(R)-3-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium |
|
C19H28NO3+ |
 |
Bortezomib Impurity W |
|
|
 |
4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one compound with (2R,3S,4R,5S)-2-(hydroxymethyl)-5-methyltetrahydrofuran-3,4-diol |
|
|
 |
Celecoxib Impurity 17 |
2247197-65-3 |
C17H14F3N3O4S |
 |
Peramivir Impurity 33 |
2758048-78-9 |
C18H34N2O5 |
 |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
![(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB32735563.gif) |
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
 |
Pramipexole impurity II |
|
|
 |
Flucloxacillin Impurity |
|
|
![Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)-](/CAS/20200515/GIF/66722-65-4.gif) |
Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)- |
66722-65-4 |
C20H33NO5 |
 |
4-(4-Piperidyl)-1-butanol |
57614-92-3 |
C9H19NO |
 |
Oseltamivir Impurity (MW:468Da) |
|
|
![3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2504210-48-2.gif) |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
![Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)-](/CAS/20210305/GIF/951313-24-9.gif) |
Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)- |
951313-24-9 |
C16H17F2NO4 |
 |
4-アミノフルオレセイン |
3326-34-9 |
C20H13NO5 |
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-](/CAS/20210305/GIF/2626934-45-8.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- |
2626934-45-8 |
C25H30Cl2N6OS2 |
 |
Brivaracet amoxidation Impurity 2 |
|
|
 |
24Dichloro-5methoxyacetanilide |
65182-98-1 |
C9H9Cl2NO2 |
 |
Apixaban Impurity 31 |
2458079-10-0 |
C27H30N4O6 |
![N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/168626-93-5.gif) |
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
168626-93-5 |
C32H25N3O3 |
 |
Sitafloxacin Impurity ZZ-B-01 |
|
|
 |
Hyoscine Butylbromide EP Impurity D |
|
|
 |
Biotin Impurity |
171232-73-8 |
C19H18N2O2S |
![N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/20200119/GIF/1374226-74-0.gif) |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |
 |
Liquiritigenin-7-O-apiosyl(1-2)-glucoside |
135432-48-3 |
C26H30O13 |
 |
Cilastatin Impurity H |
|
|
 |
1-Ethyl-2-[[(2-methoxy-5-sulphamoyl |
|
|
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
Avatrombopag Impurity 31 |
|
|
 |
Rosuvastatin Impurity 138 |
|
|
![3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid](/CAS/GIF/358390-39-3.gif) |
3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid |
358390-39-3 |
C18H20N4O4 |
![2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl-](/CAS/GIF/2276323-24-9.gif) |
2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl- |
2276323-24-9 |
C10H16N4O2 |
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
 |
Cyclosporine iMpurity |
|
|
 |
2-クロロ-1,3-ジニトロベンゼン |
606-21-3 |
C6H3ClN2O4 |
![3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE](/StructureFile/ChemBookStructure21/GIF/CB8801272.gif) |
3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE |
|
C32H36N2O4S3 |
![4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H benzimidazol-2-yl]butanoic acid](/CAS/20211123/GIF/1926162-37-9.gif) |
4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H benzimidazol-2-yl]butanoic acid |
1926162-37-9 |
C32H42Cl4N6O4 |
 |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
 |
Citalopram Impurity 14 |
1470362-85-6 |
C20H23FN2O2 |
 |
Atracurium Impurity W |
|
|
![N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide](/CAS/20210305/GIF/2514947-17-0.gif) |
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
 |
Bisoprolol Impurity 47 |
|
|
![4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY)](/CAS/GIF/72810-61-8.gif) |
4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY) |
72810-61-8 |
C13H11N3O3S |
![4,4'-[[(1-メチルエチル)イミノ]ビス[(2-ヒドロキシ-3,1-プロパンジイル)オキシ]]ビス-ベンゼンアセトアミド (ATENOLOL IMPURITY F)アテノロール不純物F](/CAS/GIF/87619-83-8.gif) |
4,4'-[[(1-メチルエチル)イミノ]ビス[(2-ヒドロキシ-3,1-プロパンジイル)オキシ]]ビス-ベンゼンアセトアミド (ATENOLOL IMPURITY F)アテノロール不純物F |
87619-83-8 |
C25H35N3O6 |
 |
Ibuprofen EP Impurity I |
2143535-26-4 |
C13H18O2 |
 |
Bumetanide Impurity 10 |
|
|
 |
Nifedipine Impurity L |
|
|
 |
Valsartan cyano analog methyl ester |
137863-90-2 |
C25H30N2O3 |
 |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
 |
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
 |
IpratropiuM BroMide IMpurity E |
183626-76-8 |
C19H27NO3 |
![[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0](/CAS/20150408/GIF/79750-46-2.gif) |
[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0 |
79750-46-2 |
C16H17N3O4S |
 |
3-Chloro TirofiBan |
2713130-63-1 |
C22H35ClN2O5S |
![3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1R)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-](/CAS/20210305/GIF/2755812-41-8.gif) |
3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1R)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)- |
2755812-41-8 |
C23H32F3N5O4 |
 |
Enrofloxacin EP Impurity E |
1369495-59-9 |
C19H22ClN3O3 |
 |
2-amino-4-fluoro-5-nitrobenzoic acid |
1194097-41-0 |
C7H5FN2O4 |
 |
Alogliptin Impurity E |
|
|
 |
DesvancosaMinyl VancoMycin |
101485-50-1 |
C59H62Cl2N8O22 |
 |
Ropivacaine Impurity 30 |
|
|
 |
Leuprorelin EP Impurity F |
1872435-00-1 |
C59H84N16O12 |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
 |
Propofol IMpurity E |
|
|
 |
2-((4S,6S)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
2165770-84-1 |
C10H19NO4 |
 |
Amifostine Impurity 3 |
41510-53-6 |
C5H15N2O3PS |
 |
Riociguat Impurtiy 4 |
|
|
 |
2-(4-ヒドロキシフェニル)-5-ヒドロキシ-3,7-ビス(β-D-グルコピラノシルオキシ)-4H-1-ベンゾピラン-4-オン |
25615-14-9 |
C27H30O16 |
![2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol](/CAS/20150408/GIF/CB02668497.gif) |
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
1858267-99-8 |
C17H26N6O4S |
![[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール)](/CAS/GIF/118457-16-2.gif) |
[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール) |
118457-16-2 |
C22H25F2NO4 |
 |
Imatinib Impurity 4 |
942514-62-7 |
C30H33N7O |
 |
Oseltamivir Impurity 103 |
|
|
 |
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
 |
Nicorandil Impurity 2 |
|
|
![(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide](/CAS/20180629/GIF/1223404-68-9.gif) |
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
 |
2-クロロ-N-(2,3-ジメチルフェニル)アセトアミド |
2564-07-0 |
C10H12ClNO |
 |
Irbesartan Impurity 5 |
1213252-81-3 |
C25H28N6O |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-95-7.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
 |
Loratadine EP Impurity L |
|
|
 |
5-BroModescyano CitalopraM |
64169-39-7 |
C19H21BrFNO |
 |
Vonoprazan Impurity 55 |
|
|
 |
((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl) methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro- 2H-pyran-2-yl)methyl acetate |
2146135-87-5 |
C26H27FO6S |
![2-Pyridinecarboxamide, 4,4′-[carbonylbis[imino(3-fluoro-4,1-phenylene)oxy]]bis[N-methyl-](/CAS/20211123/GIF/2438857-80-6.gif) |
2-Pyridinecarboxamide, 4,4′-[carbonylbis[imino(3-fluoro-4,1-phenylene)oxy]]bis[N-methyl- |
2438857-80-6 |
C27H22F2N6O5 |
![(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid](/CAS/GIF/205826-86-4.gif) |
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
 |
Isavuconazole Impurity 24 |
1176988-44-5 |
C22H17F2N5OS |
 |
Topiroxostat Impurity 14 |
|
|
 |
Cefdinir Impurity PQ(CP) |
|
|
 |
Dobutamine Impurity 3 |
334947-75-0 |
C19H25NO3 |
![4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide](/) |
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide |
|
|
 |
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
Olodaterol Impurity 25 |
|
|
 |
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
 |
Teneligliptin Impurity 2 |
|
|
 |
(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-((2R,3S)-1-(2-fluoro-6-methylbenzoyl)-3-((4-methyl-3-(trifluoromethyl)phenyl)carbamoyl)piperidin-2-yl)phenyl)piperidine-3-carboxamide |
|
|
 |
(1R,3R)-Solifenacin Succinate 2 |
740780-79-4 |
C23H26N2O2 |
![(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene](/CAS/20210111/GIF/2229745-37-1.gif) |
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
 |
AztreonaM IMpurity F |
102579-57-7 |
C15H21N5O8S2 |
 |
Rocuronium Bromide Impurity 24 、25 |
|
|
 |
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
 |
Nintedanib Impurity 27 |
|
|
 |
Topiroxostat Impurity 6 |
|
|